Literature DB >> 2011913

Serum melatonin during human pregnancy.

A Kivelä1.   

Abstract

Serum melatonin concentrations from 55 pregnant healthy women (13 during the first, 18 during the second and 24 during the third trimester) and 11 non-pregnant control women were measured radioimmunologically at 11.00 h (Study A). In addition, serum melatonin concentrations from 12 women in early and 11 women in late pregnancy were measured every four hours throughout the day (Study B). Serum melatonin levels during the third trimester of pregnancy (76.5 +/- 38.3 pmol/l) were significantly (p less than 0.01) higher than those during the first (29.7 +/- 9.9 pmol/l) and the second trimester (39.1 +/- 11.2 pmol/l) and those of non-pregnant control women (41.7 +/- 15.5 pmol/l) and there was a positive correlation between the week of gestation and serum melatonin at 11.00 h (Study A). A clear diurnal rhythm in serum melatonin concentrations was found both in early and in late pregnancy (Study B). The amplitude and duration of the nocturnal rise of melatonin were higher during late pregnancy, but there was no clear phase shift. Increased serum concentration of melatonin in late pregnancy may be due to increased synthesis and secretion or retarded metabolism of melatonin during late pregnancy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2011913

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  21 in total

1.  Pregnancy decreases rat CYP1A2 activity and expression.

Authors:  Alysa A Walker; Leslie Dickmann; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2010-10-04       Impact factor: 3.922

2.  Melatonin sensitizes human myometrial cells to oxytocin in a protein kinase C alpha/extracellular-signal regulated kinase-dependent manner.

Authors:  James T Sharkey; Casey Cable; James Olcese
Journal:  J Clin Endocrinol Metab       Date:  2010-04-09       Impact factor: 5.958

Review 3.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

4.  The reduction in circulating levels of melatonin may be associated with the development of preeclampsia.

Authors:  K Zeng; Y Gao; J Wan; M Tong; A C Lee; M Zhao; Q Chen
Journal:  J Hum Hypertens       Date:  2016-06-02       Impact factor: 3.012

5.  Dual effects of melatonin on uterine myoelectrical activity of non-pregnant rats.

Authors:  Yavuz Simşek; Hakan Parlakpınar; Uğur Turhan; Mehmet Emin Tağluk; Burhan Ateş
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-06-01

6.  Melatonin synergizes with oxytocin to enhance contractility of human myometrial smooth muscle cells.

Authors:  James T Sharkey; Roopashri Puttaramu; R Ann Word; James Olcese
Journal:  J Clin Endocrinol Metab       Date:  2008-11-11       Impact factor: 5.958

Review 7.  Peripheral reproductive organ health and melatonin: ready for prime time.

Authors:  Russel J Reiter; Sergio A Rosales-Corral; Lucien C Manchester; Dun-Xian Tan
Journal:  Int J Mol Sci       Date:  2013-04-02       Impact factor: 5.923

Review 8.  Role of melatonin in embryo fetal development.

Authors:  S E Voiculescu; N Zygouropoulos; C D Zahiu; A M Zagrean
Journal:  J Med Life       Date:  2014 Oct-Dec

9.  Melatonin modulates the fetal cardiovascular defense response to acute hypoxia.

Authors:  Avnesh S Thakor; Beth J Allison; Youguo Niu; Kimberley J Botting; Maria Serón-Ferré; Emilio A Herrera; Dino A Giussani
Journal:  J Pineal Res       Date:  2015-05-13       Impact factor: 13.007

10.  Impact of maternal melatonin suppression on forced swim and tail suspension behavioral despair tests in adult offspring.

Authors:  S E Voiculescu; A E Rosca; V Zeca; L Zagrean; A M Zagrean
Journal:  J Med Life       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.